Does Colorectal Cancer in Ulcerative Colitis Patients Constitute a Risk for Chemotherapy Refractoriness? A Systemic Approach by Detailed Analysis via the Electronic Tumor Base Documentation System

Publisher： Karger

E-ISSN： 2296-5262|34|12|688-694

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.34, Iss.12, 2011-11, pp. : 688-694

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA hypermethylation of a selective gene panel as a risk marker for colon cancer in patients with ulcerative colitis

By                

International Journal of Molecular Medicine, Vol. 31, Iss. 5, 2013-01 ,pp. : 1255-1261

Spandidos Publications

Access to resources Recommend Favorite

Comparative Analysis of Tumor Markers and Evaluation of Their Predictive Value in Patients with Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 3, 2012-02 ,pp. : 108-113

Karger

Access to resources Recommend Favorite

Adjuvant Systemic Chemotherapy with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer

By  

Oncology, Vol. 84, Iss. 1, 2012-10 ,pp. : 14-21

Karger

Access to resources Recommend Favorite

Serial profiling of circulating tumor DNA for optimization of anti‐VEGF chemotherapy in metastatic colorectal cancer patients

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 7, 2018-04 ,pp. : 1418-1426

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 5, 2015-09 ,pp. : 540-548

John Wiley & Sons Inc

Access to resources Recommend Favorite